Background
Methods
Study design
Data collection
Ethical statement
Laboratory confirmation of COVID-19
Statistical analysis
Results
Presenting characteristics
Variable | Total (%) n = 113 | Severe n = 11 | Non-severe n = 102 | P.value | Deathn = 9 | Liven = 104 | P.value |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
20–34 | 13 (11.5) | 1 (7.7) | 12 (92.3) | 0.750 | 1 (7.7) | 12 (92.3) | 0.899 |
35–49 | 36 (31.9) | 2 (5.6) | 34 (94.4) | 2 (5.6) | 34 (94.4) | ||
50–64 | 36 (31.9) | 5 (13.9) | 31 (86.1) | 3 (8.3) | 33 (91.7) | ||
65–74 | 14 (12.4) | 2 (14.3) | 12 (85.7) | 1 (7.1) | 13 (92.9) | ||
≥ 75 | 14 (12.4) | 1 (7.1) | 13 (92.9) | 2 (14.3) | 12 (85.7) | ||
Sex | |||||||
Male | 71 (62.8) | 7 (9.9) | 64 (90.1) | 0.750 | 5 (7) | 66 (93) | 0.725 |
Female | 42 (37.2) | 4 (9.5) | 38 (90.5) | 4 (9.5) | 38 (90.5) | ||
Occupation | |||||||
Healthcare worker | 3 (2.8) | 0 (0) | 3 (100) | 1.000 | 0 (0) | 3 (100) | 1.000 |
Non-healthcare worker | 103 (97.2) | 9 (8.7) | 94 (91.3) | 9 (8.7) | 94 (91.3) | ||
History of Contact with infected cases | 19 (16.8) | 0 (0) | 19 (100) | 0.206 | 0 (0) | 19 (100) | 0.353 |
History of travelling | 30 (26.5) | 3 (10) | 27 (90) | 1.000 | 2 (6.7) | 28 (93.3) | 1.000 |
Comorbid Disease | |||||||
Hypertension | 22 (19.5) | 5 (22.7) | 17 (77.3) | 0.037 | 2 (9.1) | 20 (90.9) | 1.000 |
Diabetes | 16 (14.2) | 3 (18.8) | 13 (81.3) | 0.188 | 2 (12.5) | 14 (87.5) | 0.613 |
Cardiovascular disease | 16 (14.2) | 4 (25) | 12 (75) | 0.049 | 2 (12.5) | 14 (87.5) | 0.613 |
Malignancy | 1 (0.9) | 0 (0) | 1 (100) | 1.000 | 0 (0) | 1 (100) | 1.000 |
Asthma | 7 (6.2) | 1 (14.3) | 6 (85.7) | 0.522 | 1 (14.3) | 6 (85.7) | 0.450 |
Chronic obstructive Pulmonary disease | 9 (8.0) | 1 (11.1) | 8 (88.9) | 1.000 | 1 (11.1) | 8 (88.9) | 0.540 |
Chronic kidney disease | 6 (5.3) | 0 (0) | 6 (100) | 1.000 | 0 (0) | 6 (100) | 1.000 |
Other Immunosuppressive diseases | 2 (1.8) | 0 (0) | 2 (100) | 1.000 | 0 (0) | 2 (100) | 1.000 |
Symptoms at onset of illness | |||||||
Fever | 67 (59.3) | 5 (7.5) | 62 (92.5) | 0.350 | 3 (4.5) | 64 (95.5) | 0.156 |
Cough | 73 (64.6) | 5 (6.8) | 68 (93.2) | 0.193 | 5 (6.8) | 68 (93.2) | 0.718 |
Fatigue | 75 (66.4) | 10 (13.3) | 65 (86.7) | 0.096 | 8 (10.7) | 67 (89.3) | 0.268 |
Sputum production | 24 (21.4) | 2 (8.3) | 22 (91.7) | 1.000 | 4 (16.7) | 20 (83.3) | 0.097 |
Dyspnea | 58 (51.3) | 8 (13.8) | 50 (86.2) | 0.205 | 4 (6.9) | 54 (93.1) | 0.738 |
Chest pain | 43 (38.1) | 6 (14) | 37 (86) | 0.328 | 3 (7) | 40 (93) | 1.000 |
Chills | 67 (59.3) | 4 (6) | 63 (94) | 0.114 | 3 (4.5) | 64 (95.5) | 0.153 |
Hemoptysis | 7 (6.2) | 0 (0) | 7 (100) | 1.000 | 0 (0) | 7 (100) | 1.000 |
Rhinorrhea | 26 (23.0) | 1 (3.8) | 25 (96.2) | 0.452 | 2 (7.7) | 24 (92.3) | 1.000 |
Sore throat | 36 (31.9) | 3 (8.3) | 33 (91.7) | 1.000 | 2 (5.6) | 34 (94.4) | 0.716 |
Abdominal pain | 24 (21.2) | 2 (8.3) | 22 (91.7) | 1.000 | 2 (8.3) | 22 (91.7) | 1.000 |
Diarrhea | 25 (22.1) | 1 (4) | 24 (96) | 0.451 | 2 (8) | 23 (92) | 1.000 |
Nausea | 48 (42.5) | 5 (10.4) | 43 (89.6) | 1.000 | 5 (10.4) | 43 (89.6) | 0.491 |
Vomiting | 29 (25.7) | 2 (6.9) | 27 (93.1) | 0.725 | 4 (13.8) | 25 (86.2) | 0.234 |
Anorexia | 75 (66.4) | 9 (12) | 66 (88) | 0.329 | 8 (10.7) | 67 (89.3) | 0.268 |
Myalgia /Arthralgia | 69 (61.1) | 7 (10.1) | 62 (89.9) | 1.000 | 5 (7.2) | 64 (92.8) | 0.734 |
Headache | 60 (53.1) | 5 (8.3) | 55 (91.7) | 0.753 | 6 (10) | 54 (90) | 0.498 |
Dizziness/ Vertigo | 45 (39.8) | 7 (15.6) | 38 (84.4) | 0.111 | 6 (13.3) | 39 (86.7) | 0.152 |
Conjunctival congestion | 17 (15.0) | 2 (11.8) | 15 (88.2) | 0.670 | 2 (11.8) | 15 (88.2) | 0.622 |
Physical exam on admission | |||||||
Temperature | |||||||
< 37.3 | 77 (68.1) | 8 (10.4) | 69 (89.6) | 0.005 | 6 (7.8) | 71 (92.2) | 0.002 |
37.3–38 | 24 (21.2) | 0 (0) | 24 (100) | 0 (0) | 24 (100) | ||
38.1–39 | 11 (9.7) | 2 (18.2) | 9 (81.8) | 2 (18.2) | 9 (81.8) | ||
> 39 | 1 (0.9) | 1 (0.9) | 0 (0) | 1 (100) | 0 (0) | ||
Heart Rate | |||||||
> 100 (beats/min) | 12 (10.6) | 1 (7.7) | 12 (92.3) | 1.000 | 1 (7.7) | 12 (92.3) | 1.000 |
Respiratory Rate | |||||||
> 24(breaths/min) | 2 (1.8) | 1 (50) | 1 (50) | 0.186 | 1 (50) | 1 (50) | 0.154 |
Blood Pressure | |||||||
Normal | 36 (32.4) | 4 (11.1) | 32 (88.9) | 0.738 | 4 (11.1) | 32 (88.9) | 0.617 |
Elevated | 7 (6.3) | 7 (10) | 63 (90) | 5 (7.1) | 65 (92.9) | ||
Saturation of O2 | |||||||
< 90 | 39 (34.5) | 7 (17.9) | 32 (82.1) | 0.046a | 4 (5.4) | 70 (94.6) | 0.271 |
≥ 90 | 74 (65.5) | 4 (5.4) | 70 (94.6) | 5 (12.8) | 34 (87.2) | ||
Lung Auscultation | |||||||
Respiratory Rales | 27 (23.9) | 7 (25.9) | 20 (74.1) | 0.004a | 3 (11.1) | 24.(88.9) | 0.444 |
Respiratory Wheeze | 8 (7.1) | 0 (0) | 8 (100) | 1.000 | 0 (0) | 8 (100) | 1.000 |
Respiratory Stridor | 10 (8.8) | 1 (10) | 9 (90) | 1.000 | 1 (10) | 9 (90) | 0.580 |
Other Infection Signs | |||||||
Throat Congestion | 17 (15.0) | 4 (23.5) | 13 (76.5) | 0.060 | 1 (5.9) | 16 (94.1) | 1.000 |
Swelling of tonsils | 8 (7.1) | 1 (12.5) | 7 (87.5) | 0.571 | 0 (0) | 8 (100) | 1.000 |
Lymphadenopathy | 3 (2.7) | 1 (33.3) | 2 (66.7) | 0.267 | 0 (0) | 3 (100) | 1.000 |
Rash | 6 (5.3) | 0 (0) | 6 (100) | 1.000 | 1 (16.7) | 5 (83.3) | 0.377 |
Treatment | |||||||
Anti-Viral therapy | 113 (100.0) | 11 (9.7) | 102 (90.3) | NA | 9 (8) | 104 (92) | NA |
Antibiotic therapy | 112 (99.1) | 11 (9.8) | 101 (90.2) | 1.000 | 9 (8) | 103 (92) | 1.000 |
Use of Corticosteroid | 5 (4.4) | 2 (40) | 3 (60) | 0.074 | 1 (20) | 4 (80) | 0.345 |
Oxygen support | |||||||
Nasal cannula | 31 (27.4) | 1 (3.2) | 30 (96.8) | 0.285 | 1 (3.2) | 30 (96.8) | 0.440 |
Noninvasive ventilation or high flow mask | 11 (9.8) | 6 (54.5) | 5 (45.5) | 0.000a | 1 (9.1) | 10 (90.9) | 1.000 |
Invasive mechanical ventilation | 2 (1.8) | 2 (100) | 0.000 | 0.009a | 2 (100) | 0 (0) | 0.006a |
Prognosis | |||||||
Hospitalization | 29 (25.7) | 2 (6.9) | 27 (93.1) | 0.000a | 0 (0) | 29 (100) | 0.000a |
Discharge with continued OPD treatment | 7 (6.2) | 1 (14.3) | 6 (85.7) | 0 (0) | 7 (100) | ||
Total Recovery | 68 (60.2) | 3 (4.4) | 65 (95.6) | 0 (0) | 68 (100) | ||
Death in course of Hospitalization | 9 (8) | 5 (55.6) | 4 (44.4) | 9 (100) | 0 (0) |
Vital signs and physical examination
Vital signs on admission | Mean Total (±SD)n = 113 | Mean (±SD) | P.value | Mean (±SD) | P.value | ||
---|---|---|---|---|---|---|---|
Severen = 102 | Non-Severen = 11 | Deathn = 9 | Liven = 104 | ||||
Systole Blood Pressure (mmHg) | 129.74 (±95.50) | 116.91 (±13.94) | 131 (±100.42) | 0.641 | 117.44 (±15.05) | 130.82 (±99.46) | 0.689 |
Diastole Blood Pressure (mmHg) | 74.56 (±10.68) | 77.00 (±13.12) | 74.29 (±10.42) | 0.427 | 74 (±12.28) | 74.61 (±10.58) | 0.871 |
O2 Saturation | 90.12 (±5.66) | 84.64 (±8.91) | 90.71 (±4.90) | 0.001a | 86.00 (±7.58) | 90.47 (±5.363) | 0.022a |
Respiratory rate | 18.99 (±12.88) | 19.18 (±2.994) | 18.97 (±7.02) | 0.922 | 18.89 (±2.759) | 19 (±6.979) | 0.962 |
Heart rate | 85.21 (±12.88) | 84.60 (±13.53) | 85.27 (±12.89) | 0.875 | 79.88 (±16.47) | 85.63 (±12.57) | 0.226 |
Temperature | 36.90 (±3.56) | 37.34 (±1.06) | 36.86 (±3.73) | 0.673 | 37.47 (±1.138) | 36.85 (±3.698) | 0.623 |
Laboratory findings
Laboratory Findings | Normal Value | All patients n = 113 | Sever n = 11 | Not Sever n = 102 | P.value | Dead n = 9 | Live n = 104 | P.value |
---|---|---|---|---|---|---|---|---|
White blood cell count | 3.5–9.5 | 6.06 (±2.50) | 6.62 (±2.68) | 6.00 (±2.49) | 0.438 | 6.83 (±2.94) | 6.00 (±2.47) | 0.341 |
Leukopenia | 10 (9) | 0 (0) | 10 (100) | 0.424 | 1 (10) | 9 (90) | 0.484 | |
Normal | 89 (80.2) | 9 (10.1) | 80 (89.9) | 6 (6.7) | 83 (93.3) | |||
Leukocytosis | 12 (10.8) | 2 (16.7) | 10 (83.3) | 2 (16.7) | 10 (83.3) | |||
Neutrophil count (a109/L) | 1.8–6.3 | 4.60 (±2.2) | 10.33 (±0) | 4.37 (± 1.93) | 0.006 | 6.49 (± 3.47) | 4.26 (± 1.83) | 0.064 |
1.8–6.3 | 20 (76.9) | 0 (0) | 20 (100) | 0.231 | 2 (10) | 18 (90) | 0.218 | |
> 6.3 | 6 (23.1) | 1 (16.7) | 5 (83.3) | 2 (33.3) | 4 (66.7) | |||
Lymphocyte count (a109/L) | 1.1–3.2 | 1.16 (±0.66) | 1.37 (± 0.62) | 1.14 (± 0.66) | 0.386 | 1.09 (±0.64) | 1.16 (±0.66) | 0.791 |
< 1500 | 14 (12.6) | 4 (28.6) | 10 (71.4) | 0.030a | 3 (21.4) | 11 (78.6) | 0.141 | |
1.5–3.2 | 71 (64) | 4 (5.6) | 53 (94.4) | 4 (5.6) | 67 (94.4) | |||
> 3.2 | 26 (23.4) | 3 (11.5) | 23 (88.5) | 2 (7.7) | 24 (92.3) | |||
Monocyte count (a109/L) | 0.1–0.6 | 0.49 (±0.34) | 0.46 (± 0) | 0.50 (±0.38) | 0.939 | 0.46 (± 0) | 0.50 (± 0.38) | 0.939 |
Normal | 5 (83.3) | 1 (20) | 4 (80) | 1.000 | 1 (20) | 4 (80) | 1.000 | |
Increase Monocyte count | 1 (16.6) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | |||
Hemoglobin (g/L) | 12–17.5 | 13.54 (±2.39) | 13.28 (±1.53) | 13.57 (±2.47) | 0.706 | 13.02 (±2.26) | 13.58 (±2.41) | 0.500 |
Hematocrit (%) | 36–54 | 40.42 (±4.69) | 37.05 (±10.81) | 40.66 (±4.29) | 0.301 | 40.02 (±6.6) | 40.50 (± 4.3) | 0.838 |
Platelet count | 150–450 | 220.92 (±105.66) | 220 (±108.82) | 220.98 (±105.87) | 0.985 | 199.55 (±104.24) | 222.85 (±106.09) | 0.791 |
Thrombocytopenia | 17 (15.6) | 2 (11.8) | 15 (88.2) | 0.676 | 1 (5.9) | 16 (94.1) | 0.927 | |
Normal | 80 (73.4) | 7 (8.8) | 73 (91.3) | 7 (8.8) | 73 (91.3) | |||
Thrombocytosis | 12 (11.0) | 2 (16.7) | 10 (83.3) | 1 (8.3) | 11 (91.7) | |||
Prothrombin Time (S) | 9.4–13.5 | 15.35 (±2.38) | 16.30 (±2.39) | 15.25 (±2.37) | 0.167 | 16.70 (± 1.54) | 15.23 (± 2.41) | 0.077 |
Normal | 25 (22.1) | 2 (8) | 23 (92) | 0.796 | 0 (0) | 25 (100) | 0.249 | |
Prolonged | 88 (77.9) | 9 (10.2) | 79 (89.8) | 9 (10.2) | 79 (89.8) | |||
Partial Thromboplastin Time (S) | 25–36.5 | 37.61 (±8.49) | 37.81 (±12.36) | 37.59 (±8.02) | 0.934 | 35.11 (± 10.48) | 37.84 (± 8.31) | 0.357 |
Decreased | 1 (0.9) | 2 (100) | 0 (0) | 0.000a | 1 (50) | 1 (50) | 0.100 | |
Normal | 57 (53.3) | 2 (3.6) | 54 (96.4) | 4 (7.1) | 52 (92.9) | |||
Prolonged | 49 (45.8) | 7 (14.3) | 42 (85.7) | 4 (8.2) | 45 (91.8) | |||
International Normalized Ratio | 0–1.1 | 1.32 (±0.23) | 1.85 (±0.49) | 1.28 (±0.15) | 0.000a | 1.64 (± 0.32) | 1.25 (± 0.13) | 0.000a |
Blood urea nitrogen (mg/dL) | 7–20 | 16.80 (±5.81) | 17.34 (±6.57) | 16.75 (±5.76) | 0.762 | 17.67 (± 16.73) | 16.73 (± 5.68) | 0.663 |
≤ 20 | 82 (76.6) | 8 (9.8) | 74 (90.2) | 1.000 | 6 (7.3) | 76 (92.7) | 1.000 | |
> 20 | 25 (23.4) | 2 (8) | 23 (92) | 2 (8) | 23 (92) | |||
Creatinine (mg/dL) | 0.6–1.2 | 1.13 (±0.35) | 1.22 (±0.38) | 1.12 (±0.35) | 0.418 | 1.02 (±0.29) | 1.14 (±0.36) | 0.386 |
≤ 1.2 | 69 (64.5) | 6 (8.7) | 63 (91.3) | 0.741 | 6 (8.7) | 63 (91.3) | 0.709 | |
> 1.2 | 38 (35.5) | 4 (10.5) | 34 (89.5) | 2 (5.3) | 36 (94.7) | |||
Sodium (mmol/L) | 135–145 | 137.7(±5.12) | 137.13 (±4.53) | 137.73 (±5.21) | 0.717 | 138.91 (±5.74) | 137.56 (±5.09) | 0.478 |
Potassium (mmol/L) | 3.5–5 | 4.1(±0.6) | 3.84 (±0.46) | 4.08 (±0.57) | 0.195 | 4.34 (± 0.68) | 4.04 (0.56) | 0.478 |
Lactate dehydrogenase (U/L) | 0–250 | 686.23 (±509.39) | – | 686.23 (± 509.39) | NA | 1116.5 (± 1059.95) | 628.86 (± 431.66) | 0.214 |
Aspartate aminotransferase (U/L) | 15–40 | 47.00 (±30.86) | 49.00 (± 0) | 47.00 (± 33.33) | 1.000 | 47 (± 0) | 47 (± 33.33) | 1.000 |
Alanine aminotransferase (U/L) | 9–50 | 35.87 (±36.48) | 32.00 (± 0) | 36.42 (± 39.36) | 0.920 | 32.00 (± 0) | 36.42 (±39.36) | 0.920 |
Albumin (g/L) | 3.4–5.4 | 3.90 (±0.46) | 3.90 (±0) | 3.90 (±0.47) | 0.986 | 3.90 (±0.20) | 3.90 (± 0.49) | 0.974 |
Total bilirubin (mmol/L) | 0–1.4 | 0.69 (±0.30) | 0.64 (±0) | 0.69 (±0.31) | 0.866 | 0.38 (±0.21) | 0.73 (± 0.29) | 0.063 |
Direct Bilirubin (mmol/L) | 0–0.3 | 0.34 (±0.16) | 0.31(± 0) | 0.34 (±0.16) | 0.846 | 0.23 (± 0.10) | 0.35 (±0.16) | 0.333 |
C reactive Protein (mg/L) | 0–8 | 34.32 (±20.40) | 44.00 (±24.74) | 33.33 (±19.79) | 0.116 | 35.00 (± 25.27) | 34.28 (±20.23) | 0.934 |
< 8 | 9 (8.3) | 0 (0) | 9 (100) | 0.127 | 0 (0) | 9 (100) | 0.616 | |
8–50 | 72 (66.7) | 5 (6.9) | 67 (93.1) | 5 (6.9) | 67 (93.1) | |||
≥ 50 | 27 (25) | 5 (18.5) | 22 (81.5) | 1 (3.7) | 26 (96.3) | |||
Erythrocyte sedimentation rate (mm/h) | 0–20 | 45.05 (±21.93) | 45.66 (±22.39) | 34 (±0) | 0.619 | 41.50 (± 24.89) | 46.00 (± 21.93) | 0.726 |
< 20 | 1 (0.9) | 0 (0) | 1 (100) | 1.000 | 0 (0) | 1 (100) | 1.000 | |
≥ 20 | 18 (15.9) | 1 (5.6) | 17 (94.4) | 4 (22.2) | 14 (77.8) | |||
PH | 7.35–7.45 | 7.35 (0.29) | 7.41 (±0.05) | 7.33 (±0.32) | 0.567 | |||
Acidosis | 8 (7.1) | 1 (16.7) | 5 (83.3) | 0.727 | 0 (0) | 6 (100) | 0.394 | |
Normal | 28 (24.8) | 5 (17.9) | 23 (82.1) | 5 (17.9) | 23 (82.1) | |||
Alkaline | 3 (2.7) | 0 (0) | 3 (100) | 1 (33.3) | 2 (66.7) | |||
Arterial Blood Gas | ||||||||
PCO2 | 35–48 | 44.08 (±10.73) | 42.45 (± 6.61) | 44.26 (± 11.11) | 0.615 | 46.20 (± 15.27) | 43.89 (± 10.33) | 0.563 |
PO2 | 40 | 31.24(±13.74) | 38.88 (±17.50) | 30.35 (±13.06) | 0.051 | 47.40 (± 27.23) | 29.73 (10.83) | 0.000a |
HCO3 | 35–48 | 25.62 (±3.58) | 25.91 (±3.25) | 25.58 (±3.63) | 0.789 | 25.82 (± 4.35) | 25.60 (± 3.53) | 0.868 |
Radiological findings
Variable | Total (%)n = 113 | Severe n = 11 | Non-severe n = 102 | P.value | Deathn = 9 | Liven = 104 | P.value |
---|---|---|---|---|---|---|---|
Involvement | |||||||
Normal | 4 (4.9) | 0 (0) | 4 (100) | 0.519 | 0 (0) | 4 (100) | 0.728 |
Unilateral | 8 (9.8) | 0 (0) | 8 (100) | 1 (12.5) | 7 (87.5) | ||
Bilateral | 70 (85.4) | 7 (10) | 63 (90) | 5 (7.1) | 65 (92.9) | ||
Distribution | |||||||
Diffuse | 9 (11) | 3 (33.3) | 6 (66.7) | 0.019* | 4 (44.4) | 5 (55.6) | 0.000* |
Random (Peripheral and peribronchial) | 18 (22) | 3 (16.7) | 15 (83.3) | 1 (5.6) | 17 (94.4) | ||
Peripheral | 50 (61) | 1 (2) | 49 (98) | 1 (2) | 49 (98) | ||
Peribronchial | 1 (1.2) | 0 (0) | 1 (100) | 0 (0) | 1 (100) | ||
Ground Glass Opacity | 77 (93.9) | 7 (9.1) | 70 (90.9) | 1.000 | 6 (7.8) | 71 (92.2) | 1.000 |
Crazy Paving | 40 (48.8) | 7 (17.5) | 33 (82.5) | 0.005* | 6 (15) | 34 (85) | 0.011* |
Reverse halo | 10 (12.2) | 0 (0) | 10 (100) | 0.589 | 1 (10) | 9 (90) | 0.554 |
Reticular opacity | 8 (9.8) | 1 (12.5) | 7 (87.5) | 0.527 | 0 (0) | 8 (100) | 1.000 |
Consolidation | 48 (58.5) | 4 (8.3) | 44 (91.7) | 1.000 | 3 (6.3) | 45 (93.8) | 0.688 |
Centrilobular nodule | 2 (2.4) | 0 (0) | 2 (100) | 1.000 | 0 (0) | 2 (100) | 1.000 |
Solid Nodule | 9 (11) | 0 (0) | 9 (100) | 1.000 | 0 (0) | 9 (100) | 1.000 |